U.S. federal trademark · Serial No. 98763930
Software as a service (SAAS) services featuring software for providing RNA analysis, for providing comprehensive understanding of an individual's genetic profile, and for enabling healthcare providers to make informed decisions about tailored treatment options, for targeting breast, hematological, colorectal, ovarian, head and neck, or lung cancer or PROS (PIK3CA-related overgrowth syndrome) treatment eligibility, clinical prognosis determination or clinical follow-up
Diagnostic kits consisting primarily of reagents, namely, PCR reagents used to detect and measure levels of RNA with mutations and normal copies of certain genes in human tumors, for targeting breast, hematological, colorectal, ovarian, head and neck, or lung cancer or PROS (PIK3CA-related overgrowth syndrome) treatment eligibility, clinical prognosis determination or clinical follow-up
PCR reagents used to detect and measure levels of RNA with mutations and normal copies of certain genes in human tumors, for targeting breast, hematological, colorectal, ovarian, head and neck, or lung cancer or PROS (PIK3CA-related overgrowth syndrome) treatment eligibility, clinical prognosis determination or clinical follow-up
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.